Special considerations in the use of cardiovascular drugs

Clin Obstet Gynecol. 1981 Sep;24(3):809-23. doi: 10.1097/00003081-198109000-00008.
No abstract available

Publication types

  • Review

MeSH terms

  • Anti-Arrhythmia Agents / adverse effects
  • Anticoagulants / adverse effects
  • Cardiac Glycosides / adverse effects
  • Cardiovascular Agents / adverse effects*
  • Cardiovascular Agents / therapeutic use
  • Disopyramide / adverse effects
  • Diuretics / adverse effects
  • Female
  • Fetus / drug effects
  • Humans
  • Infant, Newborn
  • Pregnancy
  • Pregnancy Complications, Cardiovascular / drug therapy
  • Procainamide / adverse effects
  • Propranolol / adverse effects
  • Quinidine / adverse effects

Substances

  • Anti-Arrhythmia Agents
  • Anticoagulants
  • Cardiac Glycosides
  • Cardiovascular Agents
  • Diuretics
  • Propranolol
  • Disopyramide
  • Quinidine
  • Procainamide